MGRB Fair Value & Analysis
US · Market cap $6.3B
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 21 days ago
Fair value updated Jun 24, 2026, revised from $26.92 to $26.58 (−1.3%) since Jun 23, 2026. Share price +2.1% over the past month.
Price vs Fair Value (12 months)
12‑month range $16.07 – $18.00 · fair‑value band $18.96 – $34.59 · the $17.16 price screens below the $26.58 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
MGRB (MGRB) currently trades at $17.16, while our model-based Fair Value estimate is $26.58, implying the stock looks roughly 54.9% undervalued today. We read business quality at 76/100 (high quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
It earns a return on equity of 13.1%. Net debt stands at $2.1B. Fundamentals as of Jun 24, 2026
Our scenario range runs from $18.96 (bear case) to $34.59 (bull case); at $17.16, the current price sits below that range. The share trades about 5% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MGRB reported revenue of $2.4B in FY2025 versus $2.4B in FY2021, a compound +0.3%/yr. Reported net income was $717M in FY2025, compounding +6.1%/yr from FY2021.
Is MGRB fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is MGRB undervalued?
What is the fair value of MGRB?
What is the quality score of MGRB?
What is the net profit margin of MGRB?
Does MGRB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full MGRB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.